Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma

Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody that is used to treat metastatic cutaneous malignant melanoma. Although bilateral uveitis has been reported as a side effect of nivolumab administration, there are few reports of Vogt-Koyanagi-Harada disease (VKH)-like uveitis....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case Reports in Ophthalmology 2019-01, Vol.10 (1), p.67-74
Hauptverfasser:	Obata, Shumpei, Saishin, Yoshitsugu, Teramura, Kazuya, Ohji, Masahito
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Case Report Case reports Case studies Cell death Complications and side effects Development and progression Drug therapy Eye examinations Immunotherapy Lung cancer Malignant melanoma Medical imaging Melanoma Meningoencephalitis Metastasis Monoclonal antibodies Nivolumab Programmed cell death protein 1 uveitis Skin cancer Targeted cancer therapy Uveitis Vogt-Koyanagi-Harada disease
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!